Literature DB >> 7964756

Benzodiazepine treatment causes uncoupling of recombinant GABAA receptors expressed in stably transfected cells.

R L Klein1, P J Whiting, R A Harris.   

Abstract

GABAA and benzodiazepine receptors are allosterically coupled, and occupation of either receptor site increases the affinity of the other. Chronic exposure of primary neuronal cultures to benzodiazepine agonists reduces these allosteric interactions. Neurons express multiple GABAA receptor subunits, and it has been suggested that uncoupling is due to changes in the subunit composition of the receptor. To determine if uncoupling could be observed with expression of defined subunits, mouse Ltk- cells stably transfected with GABAA receptors (bovine alpha 1, beta 1, and gamma 2L subunits) were treated with flunitrazepam (Flu) or clonazepam. The increase in [3H]Flu binding affinity caused by GABA (GABA shift or coupling) was significantly reduced in cells treated chronically with the benzodiazepines, whereas the KD and Bmax of [3H]Flu binding were unaffected. The uncoupling caused by clonazepam treatment occurred rapidly with a t1/2 of approximately 30 min. The EC50 for clonazepam treatment was approximately 0.3 microM, and cotreatment with the benzodiazepine antagonist Ro 15-1788 (5.6 microM) prevented the effect of clonazepam. The uncoupling observed in this system was not accompanied by receptor internalization, is unlikely to be due to changes in receptor subunit composition, and probably represents post-translational changes. The rapid regulation of allosteric coupling by benzodiazepine treatment of the stably transfected cells should provide insights to the mechanisms of coupling between GABAA and benzodiazepine receptors as well as benzodiazepine tolerance.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7964756     DOI: 10.1046/j.1471-4159.1994.63062349.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  7 in total

1.  Allosteric uncoupling and up-regulation of benzodiazepine and GABA recognition sites following chronic diazepam treatment of HEK 293 cells stably transfected with alpha1beta2gamma2S subunits of GABA (A) receptors.

Authors:  Danka Pericić; Dubravka Svob Strac; Maja Jazvinsćak Jembrek; Josipa Vlainić
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-03-22       Impact factor: 3.000

2.  The effects of zolpidem treatment and withdrawal on the in vitro expression of recombinant alpha1beta2gamma2s GABA(A) receptors expressed in HEK 293 cells.

Authors:  Josipa Vlainić; Maja Jazvinsćak Jembrek; Dubravka Svob Strac; Danka Pericić
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-07-23       Impact factor: 3.000

3.  Molecular mechanisms of benzodiazepine-induced down-regulation of GABAA receptor alpha 1 subunit protein in rat cerebellar granule cells.

Authors:  M J Brown; D R Bristow
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

4.  Differential effects of short- and long-term zolpidem treatment on recombinant α1β2γ2s subtype of GABA(A) receptors in vitro.

Authors:  Josipa Vlainić; Maja Jazvinšćak Jembrek; Toni Vlainić; Dubravka Švob Strac; Danka Peričić
Journal:  Acta Pharmacol Sin       Date:  2012-08-27       Impact factor: 6.150

5.  Training-induced changes in the expression of GABAA-associated genes in the amygdala after the acquisition and extinction of Pavlovian fear.

Authors:  Scott A Heldt; Kerry J Ressler
Journal:  Eur J Neurosci       Date:  2007-12       Impact factor: 3.386

6.  In vivo knockdown of GAD67 in the amygdala disrupts fear extinction and the anxiolytic-like effect of diazepam in mice.

Authors:  S A Heldt; L Mou; K J Ressler
Journal:  Transl Psychiatry       Date:  2012-11-13       Impact factor: 6.222

7.  A Case Report of Clonazepam Dependence: Utilization of Therapeutic Drug Monitoring During Withdrawal Period.

Authors:  Ivana Kacirova; Milan Grundmann; Petr Silhan; Hana Brozmanova
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.